KRAS and BRAF mutational status in colon cancer from Albanian patients

被引：0
作者：
Daniela Martinetti
Rosario Costanzo
Shahin Kadare
Mehdiu Alimehmeti
Cristina Colarossi
Vincenzo Canzonieri
Massimiliano Berretta
Lorenzo Memeo
机构：
[1] IOM Ricerca Srl,Department of Pathology
[2] Morphopathology Laboratories,Department of Experimental Oncology
[3] University of Tirana,Division of Pathology
[4] Mediterranean Institute of Oncology,Department of Clinical Oncology
[5] Centro di Riferimento Oncologico,undefined
[6] Centro di Riferimento Oncologico,undefined
来源：
Diagnostic Pathology | / 9卷
关键词：
Colorectal cancer; KRAS; BRAF; Albania;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   EGFR, KRAS, and BRAF mutational profiles of female patients with micropapillary predominant invasive lung adenocarcinoma [J].
Demirag, Funda ;
Yilmaz, Aydin ;
Yilmaz Demirci, Nilgun ;
Yilmaz, Ulku ;
Erdogan, Yurdanur .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (05) :1354-1361
[32]   Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients [J].
Wang, Y. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S599-S600
[33]   Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer [J].
Helgi Birgisson ;
Karolina Edlund ;
Ulrik Wallin ;
Lars Påhlman ;
Hanna Göransson Kultima ;
Markus Mayrhofer ;
Patrick Micke ;
Anders Isaksson ;
Johan Botling ;
Bengt Glimelius ;
Magnus Sundström .
BMC Cancer, 15
[34]   Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer [J].
Mi-Jung Kim ;
Hye Seung Lee ;
Jee Hyun Kim ;
Yu Jung Kim ;
Ji Hyun Kwon ;
Jeong-Ok Lee ;
Soo-Mee Bang ;
Kyoung Un Park ;
Duck-Woo Kim ;
Sung-Bum Kang ;
Jae-Sung Kim ;
Jong Seok Lee ;
Keun-Wook Lee .
BMC Cancer, 12
[35]   Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intratumor heterogeneity and mutational status [J].
Rasmy, Ayman ;
Fayed, Alaa ;
Omar, Ayman ;
Fahmy, Nermin .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (05) :886-895
[36]   Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients [J].
Yoon, Harry H. ;
Shi, Qian ;
Alberts, Steven R. ;
Goldberg, Richard M. ;
Thibodeau, Stephen N. ;
Sargent, Daniel J. ;
Sinicrope, Frank A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10)
[37]   KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma [J].
Cicenas, Jonas ;
Tamosaitis, Linas ;
Kvederaviciute, Kotryna ;
Tarvydas, Ricardas ;
Staniute, Gintare ;
Kalyan, Karthik ;
Meskinyte-Kausiliene, Edita ;
Stankevicius, Vaidotas ;
Valius, Mindaugas .
MEDICAL ONCOLOGY, 2017, 34 (02)
[38]   KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma [J].
Jonas Cicenas ;
Linas Tamosaitis ;
Kotryna Kvederaviciute ;
Ricardas Tarvydas ;
Gintare Staniute ;
Karthik Kalyan ;
Edita Meskinyte-Kausiliene ;
Vaidotas Stankevicius ;
Mindaugas Valius .
Medical Oncology, 2017, 34
[39]   KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer [J].
Renaud, S. ;
Romain, B. ;
Falcoz, P-E ;
Olland, A. ;
Santelmo, N. ;
Brigand, C. ;
Rohr, S. ;
Guenot, D. ;
Massard, G. .
BRITISH JOURNAL OF CANCER, 2015, 112 (04) :720-728
[40]   KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer [J].
S Renaud ;
B Romain ;
P-E Falcoz ;
A Olland ;
N Santelmo ;
C Brigand ;
S Rohr ;
D Guenot ;
G Massard .
British Journal of Cancer, 2015, 112 :720-728
12345